Free tool
FDA Clearance Tracker
Last checked: Nov 19, 2026Latest source record: Nov 8, 2026 (newest decision)openFDA last updated: Nov 9, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Product code SET: Immunoassay Blood Test For Amyloid Pathology Assessment. Open this device type's page
4 decisions
product code SET. Showing 1 to 4, newest first. PMA results are original approvals and panel-track supplements.
- PrecivityAD2 Test510(k)
K253240 · Decided Aug 19, 2026 · 324 days after receipt
Device type: Immunoassay Blood Test For Amyloid Pathology Assessment (SET) · Laboratory Medicine & Pathology
K261686 · Decided Aug 19, 2026 · 90 days after receipt
Device type: Immunoassay Blood Test For Amyloid Pathology Assessment (SET) · Laboratory Medicine & Pathology
- Elecsys Phospho-Tau (181P) PlasmaBreakthrough510(k)
K252163 · Decided Oct 8, 2025 · 90 days after receipt
Device type: Immunoassay Blood Test For Amyloid Pathology Assessment (SET) · Laboratory Medicine & Pathology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.